# Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and nonmyogenic pathways

**Authors:** Paola Aguiari, Valentina Villani, Yan-Yun Liu, Gianni Carraro, Gregory A. Brent, Laura Perin, Anna Milanesi

PMC · DOI: 10.1172/jci.insight.197761 · JCI Insight · 2026-03-23

## TL;DR

Hypothyroidism hinders muscle repair after injury by disrupting cell cycles, reducing muscle cell diversity, and altering immune and fibro-adipogenic processes.

## Contribution

This study reveals novel effects of hypothyroidism on myogenic heterogeneity and tissue repair through dual modes of triiodothyronine action.

## Key findings

- Hypothyroid muscles showed smaller myofibers and a shift to slower oxidative fiber types during regeneration.
- Hypothyroidism reduced myogenic-lineage diversity and delayed cell cycle progression in muscle stem cells.
- Altered nonmyogenic dynamics included elevated fibro-adipogenic progenitors and persistent proinflammatory macrophages.

## Abstract

Thyroid hormone signaling is an essential regulator of skeletal muscle development, function, and metabolism, yet the specific signaling pathways required for muscle regeneration are not yet defined. We used scRNA-seq and the FUCCI (fluorescent ubiquitination-based cell cycle indicator) reporter mouse model to examine how hypothyroidism impacts repair processes after cardiotoxin-induced injury in mice. During regeneration, and up to 2 months after injury, hypothyroid muscles displayed smaller myofibers and a shift to slower oxidative fiber types. scRNA-seq of tibialis anterior muscle during regeneration revealed that hypothyroidism reduced myogenic-lineage diversity. Cell cycle analysis confirmed delayed cell cycle progression at 5 and 14 days after injury, with skeletal muscle stem cells stalled at the G1/S transition, hindering differentiation. Transcriptomic data revealed altered nonmyogenic dynamics, including elevated activated fibro-adipogenic progenitors (FAPs) early in repair and persistent proinflammatory macrophages. Integrative regulon and ligand-receptor analysis further demonstrated that triiodothyronine acted through dual modes: a direct transcriptional control of myogenic cell cycle and oxidative programs and an indirect paracrine remodeling mediated by FAP and immune signaling networks. This study identified what we believe to be novel effects of hypothyroidism on myogenic heterogeneity and impaired tissue repair, offering insights into muscle-wasting mechanisms relevant to hypothyroidism-associated myopathy and sarcopenia.

Hypothyroidism impairs muscle regeneration by disrupting cell cycle progression, reducing myogenic diversity, and by altering fibro-adipogenic and immune cell dynamics.

## Linked entities

- **Diseases:** hypothyroidism (MONDO:0005420), myopathy (MONDO:0005336)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** H2-Eb1 (histocompatibility 2, class II antigen E beta) [NCBI Gene 14969] {aka Eb, H-2Eb, H2Eb, Ia-4, Ia4}, Myf5 (myogenic factor 5) [NCBI Gene 17877] {aka B130010J22Rik, Myf-5, bHLHc2}, Myh7 (myosin, heavy polypeptide 7, cardiac muscle, beta) [NCBI Gene 140781] {aka B-MHC, MYH-beta/slow, MyHC-I, Myhc-b, Myhcb, beta-MHC}, Ccnd1 (cyclin D1) [NCBI Gene 12443] {aka CycD1, Cyl-1, PRAD1, bcl-1, cD1}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, Ccnd3 (cyclin D3) [NCBI Gene 12445] {aka 9230106B05Rik}, Actc1 (actin, alpha, cardiac muscle 1) [NCBI Gene 11464] {aka Actc-1}, Gmnn (geminin) [NCBI Gene 57441] {aka Gem}, Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 22329] {aka CD106, Vcam-1}, Ccne1 (cyclin E1) [NCBI Gene 12447] {aka CycE1}, Cd34 (CD34 antigen) [NCBI Gene 12490], Cdkn2c (cyclin dependent kinase inhibitor 2C) [NCBI Gene 12580] {aka INK4c, p18, p18-INK4c, p18-INK6, p18INK4c}, Myf6 (myogenic factor 6) [NCBI Gene 17878] {aka MRF4, bHLHc4, herculin}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, C1qa (complement component 1, q subcomponent, alpha polypeptide) [NCBI Gene 12259] {aka Adic, C1q}, C1qb (complement component 1, q subcomponent, beta polypeptide) [NCBI Gene 12260] {aka Adia}, Thrb (thyroid hormone receptor beta) [NCBI Gene 21834] {aka Nr1a2, T3R[b], T3Rbeta, Thrb1, Thrb2, c-erbAbeta}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Myl1 (myosin, light polypeptide 1) [NCBI Gene 17901] {aka MLC1f, MLC3f, Mylf}, Ctss (cathepsin S) [NCBI Gene 13040] {aka Cats}, Cdkn1c (cyclin dependent kinase inhibitor 1C) [NCBI Gene 12577] {aka CDKI, Kip2, p57(kip2), p57Kip2}, Ccl6 (C-C motif chemokine ligand 6) [NCBI Gene 20305] {aka MRP-1, Scya6, c10}, Lama5 (laminin, alpha 5) [NCBI Gene 16776] {aka [a]5, laminin-511, mKIAA0533}, Cdk6 (cyclin dependent kinase 6) [NCBI Gene 12571] {aka Crk2}, Myog (myogenin) [NCBI Gene 17928] {aka MYF4, bHLHc3, myo}, Ptk2 (PTK2 protein tyrosine kinase 2) [NCBI Gene 14083] {aka FADK 1, FAK, FRNK, Fadk, p125FAK}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Myod1 (myogenic differentiation 1) [NCBI Gene 17927] {aka MYF3, MyoD, Myod-1, bHLHc1}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Ly6a (lymphocyte antigen 6 family member A) [NCBI Gene 110454] {aka Ly-6A.2, Ly-6A/E, Ly-6E.1, Sca-1, Sca1, TAP}, Pvalb (parvalbumin) [NCBI Gene 19293] {aka PV, Parv, Pva}, H2-Aa (histocompatibility 2, class II antigen A, alpha) [NCBI Gene 14960] {aka Aalpha, H-2Aa, H2Aa, I-Aalpha, IAalpha, Ia-1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Atp9a (ATPase, class II, type 9A) [NCBI Gene 11981] {aka IIa}, Ccna2 (cyclin A2) [NCBI Gene 12428] {aka Ccn-1, Ccn1, Ccna, CycA2, Cyca}, Acta1 (actin alpha 1, skeletal muscle) [NCBI Gene 11459] {aka Acta-2, Acts, Actsk-1}, Myh1 (myosin, heavy polypeptide 1, skeletal muscle, adult) [NCBI Gene 17879] {aka A530084A17Rik, IId, IId/x, MHC-2X/D, MHC2X/D, MYHC-IIX}, H2-Ab1 (histocompatibility 2, class II antigen A, beta 1) [NCBI Gene 14961] {aka Abeta, H-2Ab, H2-Ab, I-Abeta, IAb, Ia-2}, Ctsb (cathepsin B) [NCBI Gene 13030] {aka APPM, CB}, Car3 (carbonic anhydrase 3) [NCBI Gene 12350] {aka Ca3, Car-3}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Myh3 (myosin, heavy polypeptide 3, skeletal muscle, embryonic) [NCBI Gene 17883] {aka MyHC-emb, Myhs-e, Myhse}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, Myh4 (myosin, heavy polypeptide 4, skeletal muscle) [NCBI Gene 17884] {aka MHC2B, MM, MYH-2B, Minimsc, Minmus, MyHC-IIb}, Atp9b (ATPase, class II, type 9B) [NCBI Gene 50771] {aka Atpc2b, IIb, MMR}, Cdk2 (cyclin dependent kinase 2) [NCBI Gene 12566] {aka A630093N05Rik}, Hsf1 (heat shock factor 1) [NCBI Gene 15499] {aka HSTF, HSTF 1, Hsf1alpha, Hsf1beta}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, C1qc (complement component 1, q subcomponent, C chain) [NCBI Gene 12262] {aka Adib, C1qg, Ciqc}, Ccne2 (cyclin E2) [NCBI Gene 12448], Dio2 (deiodinase, iodothyronine, type II) [NCBI Gene 13371] {aka 5DII, DIOII}, Ccnb1 (cyclin B1) [NCBI Gene 268697] {aka Ccnb1-rs1, Ccnb1-rs13, CycB1, Cycb-4, Cycb-5, Cycb1-rs1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Coro1a (coronin, actin binding protein 1A) [NCBI Gene 12721] {aka Clabp, Lmb3, TACO, p57}, Cdt1 (chromatin licensing and DNA replication factor 1) [NCBI Gene 67177] {aka 2610318F11Rik, DUP, Ris2}, Pax7 (paired box 7) [NCBI Gene 18509] {aka Pax-7}, Thra (thyroid hormone receptor alpha) [NCBI Gene 21833] {aka 6430529J03Rik, Erba, Nr1a1, Rvr, T3R[a], T3Ralpha}
- **Diseases:** stiffness (MESH:C566112), FAP (MESH:D011125), H (MESH:D000848), muscle (MESH:D019042), muscle fiber atrophy (MESH:D009133), Thyroid hormone deficiency (MESH:D018382), cramps (MESH:D009120), injury (MESH:D014947), MuSC dysfunction (MESH:D006331), Type IIx (MESH:C562844), sarcopenia (MESH:D055948), Hypothyroid (MESH:D007037), necrotic (MESH:D009336), inflammatory (MESH:D007249), muscle injury (MESH:D009135), TAMs (MESH:D037081), myalgias (MESH:D063806), FAPs (MESH:D009810)
- **Chemicals:** paraformaldehyde (MESH:C003043), DAPI (MESH:C007293), F12 (MESH:C007782), isopentane (MESH:C067038), iodine (MESH:D007455), T4 (MESH:D013974), DMEM (-), Thr (MESH:D013912), tricarboxylic acid (MESH:D014233), CO2 (MESH:D002245), nitrogen (MESH:D009584), potassium iodate (MESH:C039693), T3 (MESH:D014284), paraffin (MESH:D010232), PTU (MESH:D011441), pm (MESH:D011399)
- **Species:** Homo sapiens (human, species) [taxon 9606], Musculus (genus) [taxon 112137], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** T3043T
- **Cell lines:** fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043096/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043096/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043096/full.md

---
Source: https://tomesphere.com/paper/PMC13043096